Sigma Planning Corp Takes $1.32 Million Position in Tempus AI, Inc. (NASDAQ:TEM)

Sigma Planning Corp bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the 3rd quarter, HoldingsChannel reports. The institutional investor bought 23,369 shares of the company’s stock, valued at approximately $1,323,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Sandia Investment Management LP bought a new position in shares of Tempus AI during the second quarter valued at $136,000. Vestor Capital LLC bought a new position in Tempus AI during the 3rd quarter worth $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in Tempus AI during the 3rd quarter worth about $258,000. Clarus Group Inc. bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $283,000. Finally, Janney Capital Management LLC bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $385,000.

Tempus AI Stock Down 12.3 %

Shares of Tempus AI stock opened at $68.04 on Wednesday. The company has a 50-day moving average price of $50.90. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 3.52.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $45.00 to $65.00 in a research note on Monday. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their price objective for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their target price on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Finally, Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up from $40.00) on shares of Tempus AI in a report on Tuesday. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $54.22.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.